These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 496138)

  • 21. Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy.
    Li F; Lu J; Cheng J; Wang L; Matsubara T; Csanaky IL; Klaassen CD; Gonzalez FJ; Ma X
    Nat Med; 2013 Apr; 19(4):418-20. PubMed ID: 23475203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hepatitis during rifampicin and isoniazid treatment of a patient with generalized tuberculosis].
    Volosevich GV
    Probl Tuberk; 1989; (9):72-3. PubMed ID: 2587561
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hydrazide-rifampicin: hepatotoxicity in children].
    Uriz Urzainqui S; Masvidal Aliberch RM; Sabriá Pau J; Bofill Bernaldo AM
    An Esp Pediatr; 1981 Oct; 15(4):401-3. PubMed ID: 7337305
    [No Abstract]   [Full Text] [Related]  

  • 24. Isoniazid-rifampicin-induced submassive hepatic necrosis.
    Kasantikul V
    J Med Assoc Thai; 1989 Jan; 72(1):56-8. PubMed ID: 2723568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How safe is isoniazid?
    Thompson JE
    Med J Aust; 1978 Feb; 1(3):165-9. PubMed ID: 651734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case of rifampicin-induced acute renal failure and review of 47 cases with liver dysfunction induced by isoniazid and rifampicin (author's transl)].
    Sugiyama Y; Kudo S; Kitamura S; Kosaka K
    Kekkaku; 1981 Jul; 56(7):375-8. PubMed ID: 7328998
    [No Abstract]   [Full Text] [Related]  

  • 27. Fatal hepatitis after treatment with isoniazid and rifampicin in a patient on anticonvulsant therapy.
    Bartelink AK; Lenders JW; van Herwaarden CL; van Haelst UJ; van Tongeren JH
    Tubercle; 1983 Jun; 64(2):125-8. PubMed ID: 6612792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Incidence of hepatotoxic side effects during antituberculous therapy (INH, RMP, EMB) in relation to the acetylator phenotype (author's transl)].
    Musch E; Eichelbaum M; Wang JK; von Sassen W; Castro-Parra M; Dengler HJ
    Klin Wochenschr; 1982 May; 60(10):513-9. PubMed ID: 7098379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Present views on isoniazid and isoniazid-rifampicin hepatitis.
    Pessayre D
    Agressologie; 1982 Jan; 23(A):13-5. PubMed ID: 7081577
    [No Abstract]   [Full Text] [Related]  

  • 30. Toxicity form rifampicin plus isoniazid and rifampicin plus ethambutol therapy.
    Lees AW; Allan GW; Smith J; Tyrrell WF; Fallon RJ
    Tubercle; 1971 Sep; 52(3):182-90. PubMed ID: 4255439
    [No Abstract]   [Full Text] [Related]  

  • 31. [Icterigenic hepatitis during the treatment with combined isoniazid and rifampicin. Clinical and experimental observations].
    Marche J; Hugues FC; Graisely B; Marche C
    Rev Tuberc Pneumol (Paris); 1971; 35(1):55-76. PubMed ID: 5559725
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hepatotoxic action of rifampicin and isonicotinic acid hydrazide].
    Kozma D; Mihalik P; Schaff Z; Lapis K
    Probl Tuberk; 1982 Jul; (7):68-72. PubMed ID: 7134213
    [No Abstract]   [Full Text] [Related]  

  • 33. Toxic hepatitis with isoniazid and rifampin. A meta-analysis.
    Steele MA; Burk RF; DesPrez RM
    Chest; 1991 Feb; 99(2):465-71. PubMed ID: 1824929
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hepatotoxic effect of a combination of pyrazinamide with isoniazid and rifampicin].
    Slivka IuI; Klimniuk EV; Tabachuk OE
    Probl Tuberk; 1989; (4):39-42. PubMed ID: 2734263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isoniazid hepatotoxicity after orthotopic liver transplantation.
    Schluger LK; Sheiner PA; Jonas M; Guarrera JV; Fiel IM; Meyers B; Berk PD
    Mt Sinai J Med; 1996; 63(5-6):364-9. PubMed ID: 8898542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatotoxicity caused by the combined action of isoniazid and rifampicin.
    Askgaard DS; Wilcke T; Døssing M
    Thorax; 1995 Feb; 50(2):213-4. PubMed ID: 7701468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of different doses of carotenoids in isoniazid-rifampicin induced hepatotoxicity in rats.
    Pal R; Rana S; Vaiphei K; Singh K
    Trop Gastroenterol; 2008; 29(3):153-9. PubMed ID: 19115607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Toxic hepatitis caused by rifampin and isoniazid in treatment of tuberculosis (author's transl)].
    Abeledo Mezquita G; Otero Reigada MC
    An Esp Pediatr; 1977 Feb; 10(2):167-70. PubMed ID: 869341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Isoniazid-rifampicin: an exemplary hepatotoxicity].
    Berthelot P
    Gastroenterol Clin Biol; 1978 Feb; 2(2):129-32. PubMed ID: 640330
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hepatotoxicity of the rifampicin-isoniazid combination in children].
    Bonora G; De La Pierre L; Perletti L
    Minerva Pediatr; 1981 Aug; 33(16):835-6. PubMed ID: 7311946
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.